ArticleMedical physics2025
Estimates of cardiac implanted electronic device neutron dose for a pencil beam scanning proton therapy system.
Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of a prospective clinical workflow for proton beam therapy of ventricular tachycardia.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- Estimates of cardiac implanted electronic device neutron dose for a pencil beam scanning proton therapy system.Medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe presence of a cardiovascular implantable electronic device (CIED) is frequently viewed as a contraindication to proton therapy due to the creation of secondary neutrons that can potentially damage CIED electronics. As a result, photon therapy is typically recommended for patients with CIEDs. PURPOSE: The study aims to provide a method for estimating neutron dose to a CIED by measuring equivalent neutron dose at varying distances from isocenter and field edge. This estimation can be used to guide clinical decisions by balancing the risk of neutron-induced CIED damage against the therapeutic benefits of proton therapy.
methodsStandardized three-dimensional measurement fields of varying dimensions were delivered using the IBA ProteusONE (Ion Beam Applications SA, Walloon Brabant, Belgium) pencil beam scanning proton therapy system, with each field delivering an RBE-weighted dose of 2 Gy. Baseline measurement included one treatment field being delivered with a range shifter. BD-PND detectors (Bubble Technology Industries, Chalk River, ON) were placed at a defined distances from the surface mark of beam isocenter and field edge to record neutron doses. Additionally, clinical treatment plans including two prostate/pelvis plans, two head & neck plans, two brain plans, and one breast plans were delivered, with detectors placed at positions corresponding to the location of a CIED.
resultsFor fields without a range shifter, the measured neutron dose ranged from 0.11 µSv/2 Gy for the smallest field at 50 cm from isocenter to 11.0 µSv/2 Gy for the largest field size at 10 cm from isocenter for fields. The addition of a range shifter to the 10 × 10 × 10 cm
conclusionThese measurements provide a foundation for estimating neutron doses to CIEDs, enabling physicists and physicians to evaluate the feasibility of proton therapy for patients with CIEDs. The results support informed clinical decision-making by quantifying the risk of neutron-induced damage relative to the therapeutic benefits of proton therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.